BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2023 8:29:43 AM | Browse: 263 | Download: 714
 |
Received |
|
2022-12-26 07:01 |
|
Peer-Review Started |
|
2022-12-26 07:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-03 05:36 |
|
Revised |
|
2023-01-17 09:51 |
|
Second Decision |
|
2023-03-08 03:08 |
|
Accepted by Journal Editor-in-Chief |
|
2023-03-09 15:55 |
|
Accepted by Executive Editor-in-Chief |
|
2023-03-17 06:14 |
|
Articles in Press |
|
2023-03-17 06:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-20 01:54 |
|
Publish the Manuscript Online |
|
2023-03-23 08:29 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Mesenchymal stem/stromal cells-derived exosomes for osteoporosis treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kai-Lun Huo, Tie-Yi Yang, Wei-Wei Zhang and Jin Shao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81703533 |
| Natural Science Foundation of Shanghai |
20ZR1449500 |
| Shanghai Jiao Tong University Medical Engineering Cross Fund |
YG2019GD02 |
| Science Technology Development Fund of Shanghai Pudong New Area |
PKJ2020-Y28 |
| Medical discipline Construction Project of Pudong Health Committee of Shanghai |
PWYts2021-05 |
|
| Corresponding Author |
Jin Shao, MD, PhD, Associate Professor, Deputy Director, Department of Orthopedics, Pudong New Area Gongli Hospital, School of Medical Technology, University of Shanghai for Science and Technology, No. 219 Miaopu Road, Pudong New Area, Shanghai 200135, China. shaojin_1977@126.com |
| Key Words |
Mesenchymal stem cells; Exosome; Osteoporosis; Osteoblasts; Osteoclasts; Bone immunity |
| Core Tip |
Osteoporosis is one of the major diseases endangering bone health in the elderly. The existing treatment drugs have problems such as long-term administration and side effects; thus, it is fundamentally difficult to cure osteoporosis. Exosomes derived from mesenchymal stem cells (MSCs) are vesicles that deliver signals and molecules between cells and have shown substantial positive effects in pre-clinical trials. In this review, we summarize the latest progress of MSCs-derived exosomes in the regulation of bone metabolism. |
| Publish Date |
2023-03-23 08:29 |
| Citation |
Huo KL, Yang TY, Zhang WW, Shao J. Mesenchymal stem/stromal cells-derived exosomes for osteoporosis treatment. World J Stem Cells 2023; 15(3): 83-89 |
| URL |
https://www.wjgnet.com/1948-0210/full/v15/i3/83.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v15.i3.83 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
